Skip to content
    CTVA
    Earnings call· Jun 2026(Q2 FY26)

    Corteva Q2 FY26 earnings call CTVA

    Jul 31, 2026 Source

    Executive summary

    Corteva Q2 FY26 — Strong First Half Performance and Raised Full-Year Outlook

    Corteva delivered a strong first half, driven by robust technology adoption, new product momentum, and growth in licensing, leading to increased full-year guidance. The company is on track for its October 1 separation, having largely offset dyssynergies. Management highlighted the strength of its differentiated technology portfolio and disciplined execution in a dynamic market.

    Highlights

    5

    • Net sales increased 4% in the first half of 2026 to $11.3 billion.

    • Operating EBITDA increased 10% in the first half of 2026 to $3.7 billion.

    • Operating EPS increased 14% in the first half of 2026.

    • Full-year operating EBITDA guidance raised to $4.1 billion to $4.3 billion, representing 9% growth at midpoint.

    • Full-year operating EPS guidance raised to $3.60 to $3.80 per share, representing 11% growth at midpoint.

    Concerns

    4

    • Crop Protection pricing remained under pressure due to competitive market dynamics, particularly in Latin America, declining low single digits in H1.

    • Expected Crop Protection pricing to decline low to mid-single digits in H2.

    • Credit is tight for Brazilian farmers, impacting order decisions closer to planting time.

    • Residual dyssynergy impact of $25 million expected this year due to timing of separation activities.

    Guidance & targets

    10
    CategoryTargetConfidence
    Full-year 2026 Operating EBITDA
    $4.1 billion to $4.3 billion
    high materiality
    High
    Full-year 2026 Operating EPS
    $3.60 to $3.80 per share
    high materiality
    High
    Full-year 2026 Operating EBITDA Margin
    22.5% to 23.5%
    medium materiality
    High
    Second Half 2026 Operating EBITDA
    about flat compared to last year
    medium materiality
    Medium
    Second Half 2026 Crop Protection Volume Growth
    high single-digit rate
    medium materiality
    High
    Second Half 2026 Crop Protection Pricing
    decline in the low to mid-single digits
    medium materiality
    High
    Second Half 2026 Seed Organic Sales Growth
    low single-digit organic sales growth
    medium materiality
    High
    Full-year 2026 Free Cash Flow Conversion
    in line with our midterm target
    medium materiality
    High
    Full-year 2026 Dyssynergies
    something in the range of a $25 million headwind
    medium materiality
    High
    Brazil corn area
    approximately flat
    medium materiality
    High

    Segment performance

    2
    SegmentRevenueYoYQoQMargin
    Seed
    Organic sales improved across every region, led by North America and EMEA, reflecting continued demand for differentiated technology and increased licensing income.
    Organic sales growth: low single digits (H1)Licensing income: increased (H1)
    		—low single digits organic sales growth (H1)——
    Crop Protection
    Pricing remained under pressure due to competitive market dynamics, particularly in Latin America. Strong adoption of new products continued to drive volume growth, partially offsetting pricing pressure.
    Pricing: declined low single digits (H1)Volumes: increased low single digits (H1)New products volume growth: high single-digit (H1)New products revenue: approaching $2 billion (FY26)
    		————

    Operational metrics

    24
    Net Sales
    $11.3 billionincreased 4% YoY
    H1 FY26

    Overall company net sales.

    Organic Sales Growth
    2%
    H1 FY26

    Overall company organic sales growth.

    Operating EBITDA
    $3.7 billionincreased 10% YoY
    H1 FY26

    Overall company operating EBITDA.

    Operating EBITDA Margin
    32.8%expanded nearly 200 bps
    H1 FY26

    Driven by value capture in Seed, productivity improvements, and disciplined cost management.

    Operating EBITDA Bridge
    $100 million
    H1 FY26

    Contributed by value-based pricing in Seed, partially offset by competitive Crop Protection pricing.

    Operating EBITDA Bridge
    $40 million
    H1 FY26

    Reflected strong North America Seed demand and high single-digit growth in Crop Protection new products.

    Operating EBITDA Bridge
    $160 million
    H1 FY26

    Through lower input costs, manufacturing efficiencies, and continued productivity initiatives.

    Operating EBITDA Bridge
    $85 million
    H1 FY26

    Primarily driven by the euro.

    Operating EBITDA Bridge
    $90 millionimproved
    H1 FY26

    Reflecting lower royalty expense and higher royalty income; expected to be net royalty positive this year.

    Crop Protection New Products Revenue
    $2 billion
    FY26

    Expected to approach this figure for the full year.

    R&D Investment
    $9 billion
    2019-2026

    Total investment since Corteva was formed.

    Cash Returned to Shareholders
    $8 billion
    2019-2026

    Total cash returned since Corteva was formed.

    Operating EBITDA Improvement
    $1.7 billion
    2019-2026

    Total improvement since Corteva was formed.

    Operating EBITDA Margin Enhancement
    750 bps
    2019-2026

    Total margin enhancement since Corteva was formed.

    Net Sales
    $6.4 billion
    Q2 FY26

    Company-wide net sales for the quarter.

    Operating EBITDA
    $2.3 billionincreased 4% YoY
    Q2 FY26

    Company-wide operating EBITDA for the quarter.

    Operating EBITDA
    $190 millionloss
    Q3 FY26

    Indicated loss for the third quarter, similar to 2024 levels.

    Operating EBITDA Growth
    $690 milliongrowth
    Q4 FY26

    Implied growth in the fourth quarter to balance second half EBITDA.

    Operating EBITDA
    $500 millionup 16% vs 2024
    H2 FY25

    Baseline for H2 FY26 flat guidance.

    Revenue Contribution
    27%
    H2 FY26

    Second half revenue as a percentage of total top line.

    EBITDA Contribution
    12%vs 13% in past 4 years
    H2 FY26

    Second half EBITDA as a percentage of full year guide, in line with historical trends.

    Productivity Cost Benefits
    $1 billion
    3-year plan

    Articulated during the last Investor Day.

    Free Cash Flow Conversion
    46%
    FY26

    Expected if backing out unusual items like pension contribution, Bayer agreement, and restructuring.

    Free Cash Flow Conversion Target
    45% to 50%
    Midterm

    Midterm target discussed at 2024 Investor Day.

    Industry KPIs

    2
    MetricValueDetails
    Volume vs price splitlow single digits (volume); low single digits (price decline)%
    Productivity cost savings program$1 billionUSD

    Orderbook & backlog

    1
    Brazil Safrinha Order Bookahead of the marketQ2 FY26

    Last year, at this point, 40% of safrinha orders were in hand. This year, the company is ahead of the market, but growers are making decisions closer to planting time due to tight credit and input costs.

    Product announcements

    2
    ProductTypeDetails
    Vylorlaunch
    Havizaroadmap

    Deals & partnerships

    1
    unnamedexpands capabilities in nature-based products

    A recent acquisition that expands Corteva's capabilities in nature-based products was mentioned.

    Risks & headwinds

    7
    Ongoing pricing pressure in pockets of the Crop Protection marketH2 FY26

    low single digits decline in H1, anticipated low to mid-single digits decline in H2

    Mitigation: Strong adoption of new products, productivity improvements, cost management, and asset optimization.

    Competitive market dynamics in Latin America (Crop Protection)H1 FY26

    pricing declined low single digits (H1)

    Mitigation: Strong adoption of new products, proactive cost structure adjustments for off-patent AIs, focus on maintaining margins and share.

    Geopolitical uncertainty and ongoing foreign exchange movementsH2 FY26

    potential impact

    Mitigation: Not explicitly stated, but implied by management's confidence in controllable factors.

    Dyssynergies from separation activitiesFY26

    $25 million headwind

    Mitigation: Largely offset on a run rate basis through efficient org structures and resource allocation.

    Tight credit for Brazilian farmersH2 FY26 (impacting Q4 orders for safrinha)

    stress on margins, growers making decisions closer to planning time

    Mitigation: Strong competitive position, product portfolio, and managing relationships side by side with farmers.

    Weather phenomena (e.g., El Niño) impacting demandH2 FY26

    lower demand for fungicide in dry regions (Europe, parts of US)

    Mitigation: Not explicitly stated, but implied by diversified portfolio and regional presence.

    Off-patent AIs leading to generic pressureOngoing

    price adjustments for certain AIs

    Mitigation: Redoing cost structures, lowering prices to maintain margins and share, focusing on new product pipeline with pricing premiums.

    What to watch in Q3 FY26

    5

    Brazil Safrinha Planted Area

    Next quarter (Q3 FY26 earnings call, reflecting Q4 order book)
    CurrentExpected approximately flat
    TargetConfirmation of planted area and order book conversion

    Why it matters

    Brazil is a key market for Seed business in H2; planted area directly impacts volume and revenue.

    We could still see that, but we also could see it flatten out a little bit in 2027. Obviously, we'll have sales orders come in at the end of this year, fourth quarter.

    Q&A highlights

    9

    What are the expectations for Brazil corn acres and pricing/mix, especially regarding Conkesta penetration, in the second half?

    Management expects Brazil corn area to be approximately flat, with strong product portfolio and pricing in Latin America. Conkesta E3 penetration is projected to be high single digits to low double digits in 2027.

    “We could still see that, but we also could see it flatten out a little bit in 2027. Obviously, we'll have sales orders come in at the end of this year, fourth quarter. Our order book is on pace with -- well, it's actually ahead of the market a little bit at this point in time.”

    asked by Vincent Andrews · answered by Charles Magro

    2 min read7 chapters

    Detailed Narrative

    01

    First Half 2026 Performance Highlights

    Corteva delivered strong first-half results with net sales up 4% to $11.3 billion, operating EBITDA up 10% to $3.7 billion, and operating EPS up 14%. This performance was attributed to robust execution in both Seed and Crop Protection, driven by technology adoption, new product momentum, licensing growth, and disciplined cost management, leading to nearly 200 basis points of margin expansion.

    02

    Separation Progress

    The company is on track for its targeted October 1 separation, having achieved several key milestones including naming Luke Kissam as CEO of New Corteva, introducing Vylor as the new seed and genetics company name, and publicly filing Form 10. Management noted that dyssynergies have been largely offset on a run rate basis, with a projected $25 million headwind this year due to timing.

    03

    Strategic Focus and Innovation

    Corteva's strategy of investing in differentiated technology, strengthening germplasm, expanding trade capabilities, and building a strong innovation pipeline is yielding measurable outcomes. The company emphasized its focus on productivity, cost management, and asset optimization, which are translating into improved margins and earnings quality even in a dynamic market.

    04

    Market Environment and Farmer Needs

    The global demand for food, feed, and biofuels continues to grow, and crop prices are up, supporting a healthy fundamental outlook. Despite tight farmer margins and cautious discretionary spending, Corteva's technology portfolio is aligned with customer needs for increased productivity and resource efficiency, reinforcing confidence in the business.

    05

    Crop Protection Dynamics

    While Crop Protection pricing faced competitive pressure, particularly in Latin America, strong adoption of new products drove volume growth. The company's strategy of building a differentiated portfolio, supported by innovation and proactive cost reduction, is working, with new products approaching $2 billion in revenue this year and maintaining flat pricing with high single-digit volume growth.

    06

    Seed Business Strength

    The Seed business saw organic growth across all regions, led by North America and EMEA, reflecting continued demand for differentiated technology and increased licensing income. The licensing business is several years ahead of its original plan, contributing significantly to the segment's performance.

    07

    Leadership Transition and Future Outlook

    CEO Chuck Magro highlighted the company's achievements since its formation in 2019, including a $1.7 billion improvement in operating EBITDA, 750 basis points of margin enhancement, nearly $9 billion invested in R&D, and $8 billion returned to shareholders. He expressed confidence in the leadership teams of both future companies and their long-term value creation opportunities.

    AI-generated summary of the company’s earnings call. Not investment advice.